Inhalation-administrated drugs remain an interesting possibility of addressing pulmonary
diseases. Direct drug delivery to the lungs allows one to obtain high concentration in the site …

Lower respiratory infections are the third leading cause of death, as stated by the world
health organization. The pulmonary route requires reduced dose, exhibits immediate drug …

With the increasing popularity and refinement of inhalation therapy, there has been a huge
demand for the design and development of fine-tuned inhalable drug particles capable of …

Introduction: Nanocomposite microparticles are intelligent carriers utilised for pulmonary
drug delivery. These carriers are composed of drug-encapsulated nanoparticles dispersed …

Design of appropriate inhaled carriers with adequate aerodynamic properties, drug release,
biodegradation and evasion of macrophage uptake is a major challenge for controlled …

Highlights•The pulmonary route is an efficient route for respiratory diseases.•Technosphere
® and PulmoSphere™ are novel inhalable technologies for drug delivery.•Microparticles are …

Delivery to the lungs is an efficient way to deliver drugs directly to the site of action or to the
blood circulation. Because of limitations of direct administration of free drugs, particulate …

Delivering drugs through inhalation for systemic and local applications has been in practice
since several decades to treat various diseases. In recent times, inhalation drug delivery is …

Dry powder inhalers are medical devices used to deliver powder formulations of active
pharmaceutical ingredients via oral inhalation to the lungs. Drug particles, from a biological …

In this study, novel biodegradable physically cross-linked hydrogel microparticles were
developed and evaluated in-vitro as potential carriers for inhalation therapy. These hydrogel …